RE:RE:RE:RE:shorts took control here....Hello melow.
I don't doubt that the company is on solid ground. PLUR needs a catalyst, aside from the steady yet non-core product contract wins.
Going forward, I expect the company to welcome some new investment, so as to expand the sales force reach and breadth. Although, I wouldn't count out the posibility being that more core product contracts would lead to one particular contract which garners the attention of a competitor, coming in early in an attempt to tuck PLUR into it's products channel. For your sake, I'd want the share price to steadily climb upward; for my own, I am calculating there will be an opportunity for a pullback in share price to the $0.56 cent price point again. That's when I'll look to get back into a plur position once again; during one of those bumps, as you put it.
Thanks for the heads up, with respect to the two companies you suggested.
Aditionally, I'll let you know that EDSA: Nasdaq had another strong move into the lower $6.00 range today. Over the past weeks, said company has moved up from the sub $5.00 range, approximately $4.69.
I don't know what it does next. Nevertheless, I am wagering, based on recent developments and the prospect of news coming from the federal government during this recently announced election campaign tour; news regarding funding provided once agin by the federal government for Edessa's transitioning into a full on phase 3 study for it's monoclonal antibody one dose treatment for COVID19 patients.
The other pick, NBM.V, seems to be in a holding pattern. Although, I suspect not for too long.
I'll certainly have a gander at STC- Sangoma Technologies and HEO- H2O Innovations, again, thanks.